[1]
Brucato A, Pluymaekers N, Tombetti E, et al. Management of idiopathic recurrent pericarditis during pregnancy. Int J Cardiol 2019; 282: 60-5.
[http://dx.doi.org/10.1016/j.ijcard.2019.02.003] [PMID: 30773267]
[http://dx.doi.org/10.1016/j.ijcard.2019.02.003] [PMID: 30773267]
[2]
Margolis G, Hertzberg-Bigelman E, Levy R, Ben-Shoshan J, Keren G, Entin-Meer M. Differential effects of colchicine on cardiac cell viability in an in vitro model simulating myocardial infarction. Cardiology 2016; 134(1): 57-64.
[http://dx.doi.org/10.1159/000443369] [PMID: 26882242]
[http://dx.doi.org/10.1159/000443369] [PMID: 26882242]
[3]
Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36(42): 2921-64.
[http://dx.doi.org/10.1093/eurheartj/ehv318] [PMID: 26320112]
[http://dx.doi.org/10.1093/eurheartj/ehv318] [PMID: 26320112]
[4]
Indraratna PL, Virk S, Gurram D, Day RO. Use of colchicine in pregnancy: A systematic review and meta-analysis. Rheumatology (Oxford) 2018; 57(2): 382-7.
[http://dx.doi.org/10.1093/rheumatology/kex353] [PMID: 29029311]
[http://dx.doi.org/10.1093/rheumatology/kex353] [PMID: 29029311]
[5]
Orabona R, Zanardini C, Zatti S, et al. Onset of idiopathic recurrent pericarditis during pregnancy: Successful management with colchicine and intravenous immunoglobulins. J Cardiovasc Med (Hagerstown) 2020; 21(5): 393-5.
[http://dx.doi.org/10.2459/JCM.0000000000000904] [PMID: 32040030]
[http://dx.doi.org/10.2459/JCM.0000000000000904] [PMID: 32040030]
Article Metrics
33
1